Subscribe to access full data
Company Business Sector Market cap ($) # net buying insiders Net value bought ($) % of float bought % of shares held by insiders
Pharmaceuticals & Medical Research Mid (2.2bn) 0 No activity — 0–15%
Healthcare Services Mid (2.2bn) -1–5 $10M–$100M 50%+ 0–15%
Pharmaceuticals & Medical Research Mid (2.2bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (2.2bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.2bn) 0 No activity — 15–50%
Healthcare Services Mid (2.2bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Mid (2.2bn) -1–5 -$10M–$100M -0–15% 15–50%
Healthcare Services Mid (2.2bn) 1–5 $100K–$1M 0–15% 0–15%
US 89Bio Inc (ETNB)
Pharmaceuticals & Medical Research Mid (2.2bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.2bn) 0 < $100K 0–15% 50%+
Pharmaceuticals & Medical Research Mid (2.2bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.2bn) 0 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.2bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.2bn) 0 No activity — 15–50%
FR Orpea SA (ORP)
Healthcare Services Mid (2.1bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.1bn) 0 No activity — 15–50%
BE Fagron NV (FAGR)
Pharmaceuticals & Medical Research Mid (2.1bn) 1–5 $100K–$1M 0–15% 0–15%
Healthcare Services Mid (2.1bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.1bn) 0 No activity — 15–50%
CH Idorsia Ltd (IDIA)
Pharmaceuticals & Medical Research Mid (2.1bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (2.1bn) 0 No activity — 0–15%
SE AddLife AB (ALIF-B)
Pharmaceuticals & Medical Research Mid (2.1bn) 1–5 < $100K 0–15% 0–15%
Healthcare Services Mid (2.1bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.1bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.1bn) -1–5 -< $100K -0–15% 50%+
Pharmaceuticals & Medical Research Mid (2.1bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Mid (2.1bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.1bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.1bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (2.0bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.0bn) 0 No activity — 0–15%
Healthcare Services Mid (2.0bn) 0 No activity — 15–50%
US Absci Corp (ABSI)
Pharmaceuticals & Medical Research Mid (2.0bn) 0 No activity — 0–15%
Healthcare Services Mid (2.0bn) 0 No activity — 0–15%
Healthcare Services Mid (2.0bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.0bn) 0 No activity — 50%+
Healthcare Services Mid (2.0bn) 1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (2.0bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Small (2.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (2.0bn) 0 No activity — 0–15%
US Quidel Corp (QDEL)
Healthcare Services Small (2.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (2.0bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Small (1.9bn) -1–5 -$10M–$100M -0–15% 0–15%
GB Genus PLC (GNS)
Pharmaceuticals & Medical Research Small (1.9bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.9bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Small (1.9bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Small (1.9bn) 0 No activity — 0–15%
Healthcare Services Small (1.9bn) 0 No activity — 0–15%
Healthcare Services Small (1.9bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.9bn) 1–5 < $100K 0–15% 15–50%
FR Emeis SA (EMEIS)
Healthcare Services Small (1.9bn) 1–5 < $100K 0–15% 0–15%
Healthcare Services Small (1.9bn) 0 No activity — 0–15%
Healthcare Services Small (1.8bn) 0 No activity — 0–15%
Healthcare Services Small (1.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Small (1.8bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) 0 No activity — 0–15%
Healthcare Services Small (1.8bn) -1–5 -$1M–$10M -0–15% 0–15%
US Azenta Inc (AZTA)
Pharmaceuticals & Medical Research Small (1.8bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) 0 No activity — 0–15%
Healthcare Services Small (1.8bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Small (1.8bn) 0 No activity — 0–15%
Healthcare Services Small (1.8bn) -6–10 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) 1–5 < $100K 0–15% 0–15%
Healthcare Services Small (1.8bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) -1–5 -< $100K -0–15% 0–15%
Healthcare Services Small (1.7bn) -6–10 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Small (1.7bn) -1–5 -$100K–$1M -0–15% 15–50%
Pharmaceuticals & Medical Research Small (1.7bn) -1–5 -$10M–$100M -0–15% 50%+
Pharmaceuticals & Medical Research Small (1.7bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) 0 No activity — 0–15%
Healthcare Services Small (1.7bn) -1–5 -$10M–$100M -0–15% 50%+
Healthcare Services Small (1.7bn) 1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Small (1.6bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.6bn) 1–5 < $100K 0–15% 15–50%
Pharmaceuticals & Medical Research Small (1.6bn) 0 No activity — 0–15%
Healthcare Services Small (1.6bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Small (1.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.6bn) 0 No activity — 0–15%
Healthcare Services Small (1.6bn) 0 No activity — 0–15%
Healthcare Services Small (1.6bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Small (1.6bn) 0 No activity — 0–15%
Healthcare Services Small (1.6bn) -1–5 -$1M–$10M -0–15% 50%+
Pharmaceuticals & Medical Research Small (1.6bn) 0 -$10M–$100M -0–15% 15–50%
Healthcare Services Small (1.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.6bn) 0 No activity — 0–15%
Loading...